IMAX Reports Record 2025 Financials, Global Box Office, and Expands Share Repurchase Program
IMAX sits 88% above its 52-week low of $20.48.
Summary
IMAX reported record financial and operating results for 2025, including all-time high global box office and significant revenue growth, alongside an expanded share repurchase program.
Key Events · Earnings and Guidance · IMAX
-
Record Financial Performance for 2025
IMAX reported 2025 revenue of $410.2 million (up 16% year-over-year), net income attributable to common shareholders of $34.9 million, and diluted EPS of $0.63. Adjusted net income reached $80.6 million, with adjusted diluted EPS of $1.45. Cash flow from operations significantly increased to $127.1 million.
-
Global Box Office Reaches All-Time High
The company achieved a record global box office of $1.28 billion in 2025, a 40% increase from 2024, surpassing its previous record set in 2019. This was driven by a record 122 new films, including 67 local language titles which generated $405.4 million in global box office.
-
IMAX Network Expands and Market Share Grows
The global IMAX network grew to 1,864 systems in 91 countries, with 98 new installations in 2025. The 'Filmed For IMAX' program contributed to a record domestic box office market share of 5.2% and a global market share of 3.8%.
-
Share Repurchase Program Increased and Extended
The Board of Directors approved a $100.0 million increase to the share repurchase program, bringing the total authorization to $500.0 million, and extended it through June 30, 2027. Approximately $250.7 million remains available under the program.
Analysis · IMAX · Industrial Applications And Services
IMAX Corporation's 2025 annual report details a year of exceptional performance, building on the preliminary results announced in a concurrent 8-K filing. The company achieved record global box office, revenue, net income, and cash flow from operations, driven by a diversified content strategy and network expansion. The significant increase and extension of the share repurchase program signals confidence in future cash generation and a commitment to shareholder returns. While a goodwill impairment and induced conversion expense were noted, the overall financial health and growth trajectory are very strong. The CEO's establishment of a 10b5-1 trading plan for option exercise is a pre-planned event, not indicative of new sentiment.
At the time of this filing, IMAX was trading at $38.45 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $2B. The 52-week trading range was $20.48 to $39.98. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.